SenL-T7 CAR T Cells for CD7+ T-cell Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
1 clinical trials · Condition
◉ Watch SenL-T7 CAR T Cells for CD7+ T-cell Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
| Record | Firm | Date |
|---|---|---|
| Clinical Study of SenL-T7 CAR T Cells in the Treatment of Relapsed and Refractory CD7+ T-cell Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma (NCT04916860) | Hebei Senlang Biotechnology Inc., Ltd. | 2021-01-27 |
Track SenL-T7 CAR T Cells for CD7+ T-cell Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.